Education
About Us
Working with TipRanks
Follow Us
Cannara Biotech (TSE:LOVE)
:LOVE
LOVE Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.57 - C$1.99
Previous CloseN/A
Volume7.64K
Average Volume (3M)82.67K
Market Cap
$160.01M
Enterprise ValueC$149.75M
Total Cash (Recent Filing)$14.41M
Total Debt (Recent Filing)$47.47M
Price to Earnings (P/E)10.2
Beta0.02
Next Earnings
Dec 02, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding91,433,136
10 Day Avg. Volume44,038
30 Day Avg. Volume82,667
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.94
Enterprise Value/Revenue1.47
Enterprise Value/Gross Profit3.29
Enterprise Value/Ebitda5.58
Forecast
1Y Price Target
$2.00Price Target Upside14.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Cannara Biotech News
LOVE FAQ
What was Cannara Biotech’s price range in the past 12 months?
Cannara Biotech lowest stock price was C$0.57 and its highest was C$1.99 in the past 12 months.
What is Cannara Biotech’s market cap?
Cannara Biotech’s market cap is $160.01M.
When is Cannara Biotech’s upcoming earnings report date?
Cannara Biotech’s upcoming earnings report date is Dec 02, 2025 which is in 82 days.
How were Cannara Biotech’s earnings last quarter?
Cannara Biotech released its earnings results on Jul 28, 2025. The company reported C$0.04 earnings per share for the quarter, beating the consensus estimate of N/A by C$0.04.
Is Cannara Biotech overvalued?
According to Wall Street analysts Cannara Biotech’s price is currently Undervalued.
Does Cannara Biotech pay dividends?
Cannara Biotech does not currently pay dividends.
What is Cannara Biotech’s EPS estimate?
Cannara Biotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cannara Biotech have?
Cannara Biotech has 91,433,136 shares outstanding.
What happened to Cannara Biotech’s price movement after its last earnings report?
Cannara Biotech reported an EPS of C$0.04 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.562%.
Which hedge fund is a major shareholder of Cannara Biotech?
Currently, no hedge funds are holding shares in TSE:LOVE
Company Description
Cannara Biotech
Cannara Biotech Inc. (LOVE) is a Canadian company focused on the production and distribution of cannabis and cannabis-derived products. Operating primarily in the regulated cannabis sector, Cannara Biotech engages in cultivation, processing, and retailing of high-quality cannabis products, including dried flower, pre-rolls, and oils. The company aims to leverage advanced cultivation techniques and state-of-the-art facilities to meet the growing demand for cannabis in both recreational and medicinal markets.
LOVE Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong financial performance with record-breaking metrics and significant market share growth in key regions and product categories. However, there are challenges in maintaining market share in certain regions and managing cash flow effectively.View all TSE:LOVE earnings summariesTechnical Analysis
Jushi Holdings
―
OrganiGram Holdings
―
Auxly Cannabis Group
―
Planet 13 Holdings
―
Decibel Cannabis Company
―
Options Prices
Currently, No data available
---